Archive for the ‘News’ Category

NPLG event on March 5, 2020

NLPG invites its members to join us for this exciting evening event focusing on opportunities and challenges related to Nordic Life Science IPOs and biotech funding. For some life sciences businesses, but surely not for all, an IPO may be the best possible scenario to secure funding, but at what cost? Is the business perhaps run even better without being listed? What are the pitfalls and what other funding opportunities may be available?

Nasdaq, Carsten Borring (Head of Listings & Capital Markets) will present their perspectives on Nordic Life Science IPOs. What key learnings has Nasdaq had for the past decades, and which trends should businesses be aware of in the years to come? Virogates, Jakob Knudsen (CEO) has kindly agreed to provide us with their experience preparing for and being a listed company. An additional pharma company is expected to provide their thoughts on Nordic IPOs.

About Nasdaq The Copenhagen Stock Exchange or CSE (Københavns Fondsbørs), since 2014 officially called Nasdaq Copenhagen, is an international marketplace for Danish securities, including shares, bonds, treasury bills and notes, and financial futures and options. Nasdaq Copenhagen is one of the Nasdaq Nordic Exchanges. Nasdaq Nordic goes back to the 2003 merger of OM AB and HEX plc to form OMX and has, since February 2008, been part of Nasdaq, Inc. (formerly known as NASDAQ OMX Group).

About Virogates ViroGates was founded in 2001, based on an invention coming from Hvidovre Hospital, Denmark. Inventor and co-founder Jesper Eugen-Olsen discovered the utility of the biomarker suPAR in HIV. More than 600 publications have followed, substantiating suPAR as one of the most promising biomarker tools for various areas of healthcare. ViroGates has developed a product line called suPARnostic® to make the suPAR test commercially available, and the ambition is to get the test implemented and used for clinical decision making.

Upcoming NPLG events


We have now set the dates for the upcoming meetings and hope that you will be able to participate in the events. Please note that you must have paid your membership fee in order to participate.

  • Networking and Dinner meeting on November 21 from 17-21. Venue is Skodsborg Kurhotel. Invited speaker is Mats Blom, CFO in Zealand Pharma. Mats will present the Zealand Pharma’s recent deal with Royalty Pharma.
  • Networking and Annual General Assembly will take place on meeting on April 25, 2019. From 17-21. Speaker to be announced.
  • Workshop/full day course on Term Sheet “What is wrong with this term sheet?” will be held on March 5, 2019 from 8.30-17.00 (Program starts at 9.00). Maximum 20 attendees. Price for members EUR 950,-


NPLG dinner and seminar “From Assumptions to Zignature” on October 26, 2017

Our next dinner and seminar will take place on the 26th of October, 2017 at Skodsborg.

We are very pleased to have both Uffe Boesen (Xplico) and Roger Lassing (LEO pharmaceuticals) present to provide us with their ins and outs on valuation “from  Assumptions to Zignature”, thereby touching upon things like valuation model building, making reasonable assumptions but also understand pitfalls wrt. misjudgements and the impact on outcomes, in addition to how to use valuation model outcomes in term sheet drafting, internal management discussion as well as in deal negotiations.

Uffe Boesen is Partner at Xplico, a Denmark based Consultancy company and a market leader in valuation support to over 75 life science companies in US and EU.

Roger Lassing is Senior Business Development Manager at LEO pharmaceuticals where is he is mainly active in working with LEO’s corporate investments and M&A.

We hope to see as many of you as possible for these exciting presentations and we expect lively discussions around these day-to-day topics for BD-ers.


15.45 – Welcome drinks

16.15 – Presentations

18.30 – Dinner (at your own costs, wine covered by NPLG).

Please confirm your attendance as soon as possible and by October 13 at the latest. We are looking forward to seeing you!

New Board and President for NPLG

March 2016: At the Annual General Assembly Meeting held on March 16, 2016, Ole Wiborg was elected as the new President of NPLG. Ole Wiborg is replacing Jürgen Langharig who is stepping down to enjoy more time with his family. Jürgen Langharig will remain on the NPLG Board as an ordinary member. Morten Fæster from Medivir was elected as new Board member and the NPLG Board now consists of Ole Wiborg (President), Jens Aakersøe (Tresurer), Jürgen Langharig, Jan Bjerrum Bach and Morten Fæster.

Deal Watch September


Skærmbillede 2014-10-08 kl. 09.17.06


Please find a Deal Watch report by Roger Davies here, and a Deal Watch table here.

NPLG Networking dinner in Chicago

2013-04-25 14.58.53[1]2013-04-21 18.08.39[1]


During BIO 2013 in Chicago, NPLG organized a dinner for NPLG members and friends in Scandinavia. About 20 people attended the dinner which took place at the famous Weber Grill restaurant. This was an excellent opportunity to get new contacts in Scandinavia and there was a lively discussion concomitant with the consumption of delicious grilled lobster and beef. A similar event will be organized in 2014.